Fundz

Eccogene Appoints Jai Patel as Chief Medical Officer

PRIVATEMay 01, 2025

Position

Chief Medical Officer

Company

Eccogene

Jai Patel
jai.patel@eccogene.com
ShanghaiBiotechnologyHealth CareTherapeuticsBiopharma

Description

Eccogene has announced the appointment of Jai Patel as its Chief Medical Officer, effective immediately. Dr. Patel brings over 30 years of experience in global clinical drug development, particularly in cardiovascular and metabolic diseases.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Eccogene, and when

A new leader at Eccogene brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Eccogene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eccogene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eccogene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eccogene

Location

Shanghai, Shanghai, China

About

Eccogene is a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions. Since its founding, Eccogene has been dedicated to discovering safer and more effective oral therapies that can be used alone or synergistically with a GLP-1 receptor agonist to treat conditions beyond obesity. The Company’s diverse pipeline of small molecule candidates leverages its world-class expertise in translational research, small molecule discovery, and a deep understanding of diabetes, weight loss and cardiometabolic disease pathways. Eccogene’s oral small molecule GLP-1 receptor agonist, ECC5004, is a potentially best-in-class asset, which was licensed to AstraZeneca. Eccogene also has clinical programs underway that target THR-β and SSAO, as well as preclinical programs targeting proven pathways, such as GIP.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eccogene changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jingye
Likely contact at this company
••••••••@••••••••

See Jingye's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Eccogene's next move

Learn about Strategic plan

Eccogene changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.